Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Diprivan Propofol 10mg/mL Emulsion for injection AstraZeneca Limited Fresenius Kabi AB, Uppsala, Sweden Corden Pharma SpA, Milan, Italy
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Diprivan Propofol 20mg/mL Emulsion for injection AstraZeneca Limited Corden Pharma SpA, Milan, Italy
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Eylea Aflibercept 40mg/mL Solution for injection Bayer New Zealand Limited Regeneron Pharmaceuticals Inc, New York, United States of America
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Galvus Met Metformin hydrochloride 850mg Vildagliptin 50mg Film coated tablet Novartis New Zealand Limited Novartis Pharma Stein AG, Stein, Switzerland Novartis Pharma Produktions GmbH, Wehr, Germany Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Galvus Met Metformin hydrochloride 1000mg Vildagliptin 50mg Film coated tablet Novartis New Zealand Limited Novartis Pharma Stein AG, Stein, Switzerland Novartis Pharma Produktions GmbH, Wehr, Germany Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
|
Dated this 30th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).